nach oben

The International Journal of Cardiovascular Imaging

Erschienen in:

31.03.2017 | Review Paper

Magnetic resonance imaging for characterizing myocardial diseases

verfasst von: Maythem Saeed, Hui Liu, Chang-Hong Liang, Mark W. Wilson

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Abstract

The National Institute of Health defined cardiomyopathy as diseases of the heart muscle. These myocardial diseases have different etiology, structure and treatment. This review highlights the key imaging features of different myocardial diseases. It provides information on myocardial structure/orientation, perfusion, function and viability in diseases related to cardiomyopathy. The standard cardiac magnetic resonance imaging (MRI) sequences can reveal insight on left ventricular (LV) mass, volumes and regional contractile function in all types of cardiomyopathy diseases. Contrast enhanced MRI sequences allow visualization of different infarct patterns and sizes. Enhancement of myocardial inflammation and infarct (location, transmurality and pattern) on contrast enhanced MRI have been used to highlight the key differences in myocardial diseases, predict recovery of function and healing. The common feature in many forms of cardiomyopathy is the presence of diffuse-fibrosis. Currently, imaging sequences generating the most interest in cardiomyopathy include myocardial strain analysis, tissue mapping (T₁, T_2, T₂*) and extracellular volume (ECV) estimation techniques. MRI sequences have the potential to decode the etiology by showing various patterns of infarct and diffuse fibrosis in myocarditis, amyloidosis, sarcoidosis, hypertrophic cardiomyopathy due to aortic stenosis, restrictive cardiomyopathy, arrythmogenic right ventricular dysplasia and hypertension. Integrated PET/MRI system may add in the future more information for the diagnosis and progression of cardiomyopathy diseases. With the promise of high spatial/temporal resolution and 3D coverage, MRI will be an indispensible tool in diagnosis and monitoring the benefits of new therapies designed to treat myocardial diseases.

Nicolas WS, Rafat FP, Edmund PC (2013) Pericarditis, myocarditis, and other cardiomyopathies. Prim Care 40:213–236CrossRef

Earls JP, Ho VB, Foo TK, Castillo E, Flamm SD (2002) Cardiac mri: recent progress and continued challenges. J Magn Resone Imaging 16:111–127CrossRef

McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, Pennell DJ (2003) Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108:54–59PubMedCrossRef

De Cobelli F, Pieroni M, Esposito A, Chimenti C, Belloni E, Mellone R, Canu T, Perseghin G, Gaudio C, Maseri A, Frustaci A, Del Maschio A (2006) Delayed gadolinium-enhanced cardiac magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias. J Am Coll Cardiol 47:1649–1654PubMedCrossRef

Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M, Sheppard MN, Poole-Wilson PA, Pennell DJ (2006) Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48:1977–1985PubMedCrossRef

Saremi F, Grizzard JD, Kim RJ (2008) Optimizing cardiac mr imaging: practical remedies for artifacts. Radiographics 28:1161–1187PubMedCrossRef

Markl M, Pelc NJ (2004) On flow effects in balanced steady-state free precession imaging: pictorial description, parameter dependence, and clinical implications. J Magn Reson Imaging 20:697–705PubMedCrossRef

Schar M, Kozerke S, Fischer SE, Boesiger P (2004) Cardiac ssfp imaging at 3 T. Magn Reson Med 51:799–806PubMedCrossRef

Chavhan GB, Babyn PS, Jankharia BG, Cheng HL, Shroff MM (2008) Steady-state mr imaging sequences: physics, classification, and clinical applications. Radiographics 28:1147–1160PubMedCrossRef

10.

Deux JF, Maatouk M, Lim P, Vignaud A, Mayer J, Gueret P, Rahmouni A (2011) Acute myocarditis: diagnostic value of contrast-enhanced cine steady-state free precession mri sequences. Am J Roentgenol 197:1081–1087CrossRef

11.

Giri S, Chung YC, Merchant A, Mihai G, Rajagopalan S, Raman SV (2009) T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson 11:56. doi:10.1186/1532-429X-11-56 PubMedPubMedCentralCrossRef

12.

Abdel-Aty H, Boye P, Zagrosek A, Wassmuth R, Kumar A, Messroghli D (2005) Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 45:1815–1822CrossRef

13.

Abdel-Aty H, Cocker M, Friedrich MG (2009) Myocardial edema is a feature of tako-tsubo cardiomyopathy and is related to the severity of systolic dysfunction: insights from t2-weighted cardiovascular magnetic resonance. Int J Cardiol 132:291–293PubMedCrossRef

14.

Sosnovik DE, Wang R, Dai G, Reese TG, Wedeen VJ (2009) Diffusion mr tractography of the heart. J Cardiovasc Magn Reson 11:47PubMedPubMedCentralCrossRef

15.

Hales PW, Schneider JE, Burton RA, Wright BJ, Bollensdorff C, Kohl P (2012) Histo-anatomical structure of the living isolated rat heart in two contraction states assessed by diffusion tensor MRI. Prog Biophys Mol Biol 110:319–330PubMedPubMedCentralCrossRef

16.

Cao F, Lin S, Xie X, Ray P, Patel M, Zhang X, Drukker M, Dylla SJ, Connolly AJ, Chen X, Weissman IL, Gambhir SS, Wu JC (2006) In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation 113:1005–1014PubMedPubMedCentralCrossRef

17.

Mekkaoui C, Huang S, Chen HH, Dai G, Reese TG, Kostis WJ, Thiagalingam A, Maurovich-Horvat P, Ruskin JN, Hoffmann U, Jackowski MP, Sosnovik DE (2012) Fiber architecture in remodeled myocardium revealed with a quantitative diffusion cmr tractography framework and histological validation. J Cardiovasc Magn Reson 14:70PubMedPubMedCentralCrossRef

18.

McGill LA, Ismail TF, Nielles-Vallespin S, Ferreira P, Scott AD, Roughton M, Kilner PJ, Ho SY, McCarthy KP, Gatehouse PD, de Silva R, Speier P, Feiweier T, Mekkaoui C, Sosnovik DE, Prasad SK, Firmin DN, Pennell DJ (2012) Reproducibility of in-vivo diffusion tensor cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 14:86PubMedPubMedCentralCrossRef

19.

Ferreira PF, Kilner PJ, McGill LA, Nielles-Vallespin S, Scott AD, Ho SY, McCarthy KP, Haba MM, Ismail TF, Gatehouse PD, de Silva R, Lyon AR, Prasad SK, Firmin DN, Pennell DJ (2014) In vivo cardiovascular magnetic resonance diffusion tensor imaging shows evidence of abnormal myocardial laminar orientations and mobility in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 16:87PubMedPubMedCentralCrossRef

20.

Tseng YY, Liang J (2006) Estimation of amino acid residue substitution rates at local spatial regions and application in protein function inference: a bayesian monte carlo approach. Mol Biol Evol 23:421–436PubMedCrossRef

21.

Ismail TF, Hsu LY, Greve AM, Goncalves C, Jabbour A, Gulati A, Hewins B, Mistry N, Wage R, Roughton M, Ferreira PF, Gatehouse P, Firmin D, O’Hanlon R, Pennell DJ, Prasad SK, Arai AE (2014) Coronary microvascular ischemia in hypertrophic cardiomyopathy-a pixel-wise quantitative cardiovascular magnetic resonance perfusion study. J Cardiovasc Magn Reson 16:49PubMedPubMedCentralCrossRef

22.

Laissy JP, Gaxotte V, Ironde-Laissy E, Klein I, Ribet A, Bendriss A, Chillon S, Schouman-Claeys E, Steg PG, Serfaty JM (2013) Cardiac diffusion-weighted mr imaging in recent, subacute, and chronic myocardial infarction: a pilot study. J Magn Reson Imaging 38:1377–1387PubMedCrossRef

23.

Lund GK, Stork A, Saeed M, Bansmann MP, Gerken JH, Muller V, Mester J, Higgins CB, Adam G, Meinertz T (2004) Acute myocardial infarction: evaluation with first-pass enhancement and delayed enhancement mr imaging compared with 201tl spect imaging. Radiology 232:49–57PubMedCrossRef

24.

Wu E, Ortiz JT, Tejedor P, Lee DC, Bucciarelli-Ducci C, Kansal P, Carr JC, Holly TA, Lloyd-Jones D, Klocke FJ, Bonow RO (2008) Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Heart 94:730–736PubMedCrossRef

25.

Roes SD, Kelle S, Kaandorp TA, Kokocinski T, Poldermans D, Lamb HJ, Boersma E, van der Wall EE, Fleck E, de Roos A, Nagel E, Bax JJ (2007) Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction. Am J Cardiol 100:930–936PubMedCrossRef

26.

Masci PG, Ganame J, Strata E, Desmet W, Aquaro GD, Dymarkowski S (2010) Myocardial salvage by cmr correlates with lv remodeling and early st-segment resolution in acute myocardial infarction. JACC Cardiovasc Imaging 3(1):45–51. doi:10.1016/j.jcmg.2009.06.016 PubMedCrossRef

27.

Wu KC (2012) Cmr of microvascular obstruction and hemorrhage in myocardial infarction. J Cardiovasc Magn Reson 14:68PubMedPubMedCentralCrossRef

28.

Bajwa HZ, Do L, Suhail M, Hetts SW, Wilson MW, Saeed M (2014) Mri demonstrates a decrease in myocardial infarct healing and increase in compensatory ventricular hypertrophy following mechanical microvascular obstruction. J Magn Reson Imaging 40:906–914PubMedCrossRef

29.

Ahmed N, Carrick D, Layland J, Oldroyd KG, Berry C (2013) The role of cardiac magnetic resonance imaging (mri) in acute myocardial infarction (ami). Heart lung circulation 22:243–255CrossRef

30.

Rubenstein JC, Lee DC, Wu E, Kadish AH, Passman R, Bello D, Goldberger JJ (2013) A comparison of cardiac magnetic resonance imaging peri-infarct border zone quantification strategies for the prediction of ventricular tachyarrhythmia inducibility. Cardiol J 20:68–77PubMedCrossRef

31.

Kvernby S, Warntjes MJ, Haraldsson H, Carlhall CJ, Engvall J, Ebbers T (2014) Simultaneous three-dimensional myocardial t1 and t2 mapping in one breath hold with 3d-qalas. J Cardiovasc Magn Reson 16:102PubMedPubMedCentralCrossRef

32.

Luetkens JA, Homsi R, Sprinkart AM, Doerner J, Dabir D, Kuetting DL, Block W, Andrié R, Stehning C, Fimmers R, Gieseke J, Thomas DK, Schild HH, Naehle CP (2016) Incremental value of quantitative cmr including parametric mapping for the diagnosis of acute myocarditis. Eur Heart J Cardiovasc Imaging 17:154–161PubMedCrossRef

33.

Puntmann VO, D’Cruz D, Smith Z, Pastor A, Choong P, Voigt T, Carr-White G, Sangle S, Schaeffter T, Nagel E (2013) Native myocardial t1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Circ Cardiovasc Imaging 6:295–301PubMedCrossRef

34.

Mordi I, Carrick D, Bezerra H, Tzemos N (2015) T1 and t2 mapping for early diagnosis of dilated non-ischaemic cardiomyopathy in middle-aged patients and differentiation from normal physiological adaptation. Eur Heart J Cardiovasc Imaging 17:797–803PubMedCrossRef

35.

Hinojar R, Varma N, Child N, Goodman B, Jabbour A, Yu CY, Gebker R, Doltra A, Kelle S, Khan S, Rogers T, Arroyo Ucar E, Cummins C, Carr-White G, Nagel E, Puntmann VO (2015) T1 mapping in discrimination of hypertrophic phenotypes: hypertensive heart disease and hypertrophic cardiomyopathy: findings from the international t1 multicenter cardiovascular magnetic resonance study. Circ Cardiovasc Imaging 8(12):e003285. doi:10.1161/CIRCIMAGING.115.003285 PubMedCrossRef

36.

Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M, Gatehouse PD, Arai AE, Friedrich MG, Neubauer S, Schulz-Menger J, Schelbert EB (2013) Myocardial t1 mapping and extracellular volume quantification: a society for cardiovascular magnetic resonance (scmr) and cmr working group of the european society of cardiology consensus statement. J Cardiovasc Magn Reson 15:92PubMedPubMedCentralCrossRef

37.

Saeed MHS, Jablonowski R, Wilson MW (2014) Magnetic resonance imaging and multi-detector computed tomography assessment of extracellular compartment in ischemic and non-ischemic myocardial pathologies. World J Cardiol 6:1192–1208PubMedPubMedCentralCrossRef

38.

Saeed M, Bajwa HZ, Do L, Hetts SW, Wilson MW (2016) Multi-detector ct and mri of microembolized myocardial infarct: monitoring of left ventricular function, perfusion, and myocardial viability in a swine model. Acta Radiol 57:215–224PubMedCrossRef

39.

Saeed M, Hetts SW, Do L, Wilson MW (2013) Coronary microemboli effects in preexisting acute infarcts in a swine model: cardiac mr imaging indices, injury biomarkers, and histopathologic assessment. Radiology 268:98–108PubMedCrossRef

40.

Nallamothu BK, Bates ER (2003) Periprocedural myocardial infarction and mortality: causality versus association. J Am Coll Cardiol 42:1412–1414PubMedCrossRef

41.

Schwartz RS, Burke A, Farb A, Kaye D, Lesser JR, Henry TD, Virmani R (2009) Microemboli and microvascular obstruction in acute coronary thrombosis and sudden coronary death: relation to epicardial plaque histopathology. J Am Coll Cardiol 54:2167–2173PubMedCrossRef

42.

Saeed M, Lund G, Wendland MF, Bremerich J, Weinmann H, Higgins CB (2001) Magnetic resonance characterization of the peri-infarction zone of reperfused myocardial infarction with necrosis-specific and extracellular nonspecific contrast media. Circulation 103:871–876PubMedCrossRef

43.

Yan AT, Shayne AJ, Brown KA, Gupta SN, Chan CW, Luu TM, Di Carli MF, Reynolds HG, Stevenson WG, Kwong RY (2006) Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 114:32–39PubMedCrossRef

44.

Schmidt A, Azevedo CF, Cheng A, Gupta SN, Bluemke DA, Foo TK, Gerstenblith G, Weiss RG, Marban E, Tomaselli GF, Lima JA, Wu KC (2007) Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 115:2006–2014PubMedPubMedCentralCrossRef

45.

O’Regan DP, Ahmed R, Neuwirth C, Tan Y, Durighel G, Hajnal JV, Nadra I, Corbett SJ, Cook SA (2009) Cardiac mri of myocardial salvage at the peri-infarct border zones after primary coronary intervention. Am J Physiol Heart Circ Physiol 297:H340–H346PubMedPubMedCentralCrossRef

46.

Lund GK, Stork A, Muellerleile K, Barmeyer AA, Bansmann MP, Knefel M, Schlichting U, Muller M, Verde PE, Adam G, Meinertz T, Saeed M (2007) Prediction of left ventricular remodeling and analysis of infarct resorption in patients with reperfused myocardial infarcts by using contrast-enhanced mr imaging. Radiology 245:95–102PubMedCrossRef

47.

Pokorney SD, Rodriguez JF, Ortiz JT, Lee DC, Bonow RO, Wu E (2012) Infarct healing is a dynamic process following acute myocardial infarction. J Cardiovasc Magn Reson 14:62PubMedPubMedCentralCrossRef

48.

Gupta A, Lee VS, Chung YC, Babb JS, Simonetti OP (2004) Myocardial infarction: optimization of inversion times at delayed contrast-enhanced mr imaging. Radiology 233:921–926PubMedCrossRef

49.

Kellman P, Hansen MS (2014) T1-mapping in the heart: accuracy and precision. J Cardiovasc Magn Reson 16:2PubMedPubMedCentralCrossRef

50.

Treibel TA, Fontana M, Gilbertson JA, Castelletti S, White SK, Scully PR, Roberts N, Hutt DF, Rowczenio DM, Whelan CJ, Ashworth MA, Gillmore JD, Hawkins PN, Moon JC (2016) Occult transthyretin cardiac amyloid in severe calcific aortic stenosis: prevalence and prognosis in patients undergoing surgical aortic valve replacement. Circ Cardiovasc Imaging 9(8):e005066. doi:10.1161/CIRCIMAGING.116.005066

51.

Yoon JH, Son JW, Chung H, Park CH, Kim YJ, Chang HJ, Hong GR, Kim TH, Ha JW, Choi BW, Rim SJ, Chung N, Choi EY (2015) Relationship between myocardial extracellular space expansion estimated with post-contrast t1 mapping mri and left ventricular remodeling and neurohormonal activation in patients with dilated cardiomyopathy. Korean J Radiol 16:1153–1162PubMedPubMedCentralCrossRef

52.

Barison A, Emdin M, Masci PG (2016) Increased extracellular volume fraction in nonischaemic dilated cardiomyopathy predicts worse outcomes independently of medical therapy. J Cardiovasc Med 17:227CrossRef

53.

Germain P, El Ghannudi S, Jeung MY, Ohlmann P, Epailly E, Roy C, Gangi A (2014) Native t1 mapping of the heart-a pictorial review. Clin Med Insights Cardiol 8:1–11PubMedPubMedCentralCrossRef

54.

Pennell D (2006) Myocardial salvage: retrospection, resolution, and radio waves. Circulation 113:1821–1823PubMedCrossRef

55.

Abdel-Aty H, Simonetti O, Friedrich MG (2007) T2-weighted cardiovascular magnetic resonance imaging. J Magn Reson Imaging 26:452–459PubMedCrossRef

56.

Aletras AH, Tilak GS, Natanzon A, Hsu LY, Gonzalez FM, Hoyt RF Jr, Arai AE (2006) Retrospective determination of the area at risk for reperfused acute myocardial infarction with t2-weighted cardiac magnetic resonance imaging: Histopathological and displacement encoding with stimulated echoes (dense) functional validations. Circulation 113:1865–1870PubMedCrossRef

57.

Desch S, Eitel I, de Waha S, Fuernau G, Lurz P, Gutberlet M, Schuler G, Thiele H (2011) Cardiac magnetic resonance imaging parameters as surrogate endpoints in clinical trials of acute myocardial infarction. Trials 12:204PubMedPubMedCentralCrossRef

58.

Ibanez B, Macaya C, Sanchez-Brunete V, Pizarro G, Fernandez-Friera L, Mateos A, Fernandez-Ortiz A, Garcia-Ruiz JM, Garcia-Alvarez A, Iniguez A, Jimenez-Borreguero J, Lopez-Romero P, Fernandez-Jimenez R, Goicolea J, Ruiz-Mateos B, Bastante T, Arias M, Iglesias-Vazquez JA, Rodriguez MD, Escalera N, Acebal C, Cabrera JA, Valenciano J, Perez de Prado A, Fernandez-Campos MJ, Casado I, Garcia-Rubira JC, Garcia-Prieto J, Sanz-Rosa D, Cuellas C, Hernandez-Antolin R, Albarran A, Fernandez-Vazquez F, de la Torre-Hernandez JM, Pocock S, Sanz G, Fuster V (2013) Effect of early metoprolol on infarct size in st-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the effect of metoprolol in cardioprotection during an acute myocardial infarction (metocard-cnic) trial. Circulation 128:1495–1503PubMedCrossRef

59.

Eitel I, Friedrich MG (2011) T2-weighted cardiovascular magnetic resonance in acute cardiac disease. J Cardiovasc Magn Reson 13:1–11CrossRef

60.

Fernandez-Jimenez R, Sanchez-Gonzalez J, Aguero J, Garcia-Prieto J, Lopez-Martin GJ, Garcia-Ruiz JM, Molina-Iracheta A, Rossello X, Fernandez-Friera L, Pizarro G, Garcia-Alvarez A, Dall’Armellina E, Macaya C, Choudhury RP, Fuster V, Ibanez B (2015) Myocardial edema after ischemia/reperfusion is not stable and follows a bimodal pattern: imaging and histological tissue characterization. J Am Coll Cardiol 65:315–323PubMedCrossRef

61.

Wood JC (2011) Impact of iron assessment by mri. Hematol Am Soc Hematol Educ Progr 2011:443–450

62.

Ouederni M, Ben Khaled M, Mellouli F, Ben Fraj E, Dhouib N, Yakoub IB, Abbes S, Mnif N, Bejaoui M (2017) Myocardial and liver iron overload, assessed using t2* magnetic resonance imaging with an excel spreadsheet for post processing in tunisian thalassemia major patients. Ann Hematol 96:133–139PubMedCrossRef

63.

Carpenter JP, Pennell DJ (2009) Role of t2* magnetic resonance in monitoring iron chelation therapy. Acta Haematol 122:146–154PubMedCrossRef

64.

Raman SV, Winner MW III, Tran T, Velayutham M, Simonetti OP, Baker PB, Olesik J, McCarthy B, Ferketich AK, Zweier JL (2008) In vivo atherosclerotic plaque characterization using magnetic susceptibility distinguishes symptom-producing plaques. JACC Cardiovasc Imaging 1(1):49–57. doi:10.1016/j.jcmg.2007.09.002 PubMedPubMedCentralCrossRef

65.

Tanner MA, Porter JB, Westwood MA et al (2005) Myocardial t2* in patients with cardiac failure secondary to iron overload. Blood 107(9):3738–3744

66.

Abdel-Gadir A, Sado D, Murch S, Maestrini V, Rosmini S, Treibel TA, Fontana M, Bulluck H, Piechnik SK, Manisty C, Herrey AS, Walker JM, Porter J, Moon J (2015) Myocardial iron quantification using t2* and native t1mapping-a 250 patient study. J Cardiovasc Magn Reson 17:1–2CrossRef

67.

Pennell DJ (2008) T2* magnetic resonance: Iron and gold. JACC Cardiovasc Imaging 1:579–581PubMedCrossRef

68.

Coelho-Filho OR, Rickers C, Kwong RY, Jerosch-Herold M (2013) Mr myocardial perfusion imaging. Radiology 266:701–715PubMedCrossRef

69.

Moffat BA, Chenevert TL, Hall DE, Rehemtulla A, Ross BD (2005) Continuous arterial spin labeling using a train of adiabatic inversion pulses. J Magn Reson Imaging 21:290–296PubMedCrossRef

70.

Theberge J (2008) Perfusion magnetic resonance imaging in psychiatry. Top Magn Reson Imaging 19:111–130PubMedCrossRef

71.

Arnold JR, Karamitsos TD, Bhamra-Ariza P, Francis JM, Searle N, Robson MD, Howells RK, Choudhury RP, Rimoldi OE, Camici PG, Banning AP, Neubauer S, Jerosch-Herold M, Selvanayagam JB (2012) Myocardial oxygenation in coronary artery disease: insights from blood oxygen level-dependent magnetic resonance imaging at 3 T. J Am Coll Cardiol 59:1954–1964PubMedCrossRef

72.

Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, Bijsterveld P, Ridgway JP, Radjenovic A, Dickinson CJ, Ball SG, Plein S (2012) Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (ce-marc): a prospective trial. Lancet 379:453–460PubMedPubMedCentralCrossRef

73.

Sipola P, Lauerma K, Husso-Saastamoinen M, Kuikka JT, Vanninen E, Laitinen T, Manninen H, Niemi P, Peuhkurinen K, Jaaskelainen P, Laakso M, Kuusisto J, Aronen HJ (2003) First-pass mr imaging in the assessment of perfusion impairment in patients with hypertrophic cardiomyopathy and the asp175asn mutation of the alpha-tropomyosin gene. Radiology 226:129–137PubMedCrossRef

74.

Kuribayashi T, Roberts WC (1992) Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. Am J Cardiol 70:1333–1340PubMedCrossRef

75.

Jahnke C, Nagel E, Gebker R, Kokocinski T, Kelle S, Manka R, Fleck E, Paetsch I (2007) Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation 115:1769–1776PubMedCrossRef

76.

Nahrendorf M, Pittet MJ, Swirski FK (2010) Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation 121:2437–2445PubMedPubMedCentralCrossRef

77.

Alam SR, Shah ASV, Richards J, Lang NN, Barnes G, Joshi N, MacGillivray T, McKillop G, Mirsadraee S, Payne J, Fox KAA, Henriksen P, Newby DE, Semple SIK (2012) Ultrasmall superparamagnetic particles of iron oxide in patients with acute myocardial infarction: early clinical experience. Circulation 5:559–565PubMed

78.

Yilmaz A, Dengler MA, van der Kuip H, Yildiz H, Rösch S, Klumpp S, Klingel K, Kandolf R, Helluy X, Hiller K-H, Jakob PM, Sechtem U (2013) Imaging of myocardial infarction using ultrasmall superparamagnetic iron oxide nanoparticles: a human study using a multi-parametric cardiovascular magnetic resonance imaging approach. Eur Heart J 34:462–475PubMedCrossRef

79.

Rischpler C, Nekolla SG, Dregely I, Schwaiger M (2013) Hybrid pet/mr imaging of the heart: potential, initial experiences, and future prospects. J Nucl Med 54:402–415PubMedCrossRef

80.

Rischpler C, Dirschinger RJ, Nekolla SG, Kossmann H, Nicolosi S, Hanus F, van Marwick S, Kunze KP, Meinicke A, Götze K, Kastrati A, Langwieser N, Ibrahim T, Nahrendorf M, Schwaiger M, Laugwitz K-L (2016) Prospective evaluation of 18 f-fluorodeoxyglucose uptake in postischemic myocardium by simultaneous positron emission tomography/magnetic resonance imaging as a prognostic marker of functional outcome. Circulation 9:e004316PubMedPubMedCentral

81.

Carlsson M, Osman NF, Ursell PC, Martin AJ, Saeed M (2008) Quantitative mr measurements of regional and global left ventricular function and strain after intramyocardial transfer of vm202 into infarcted swine myocardium. Am J Physiol Heart Circ Physiol 295:H522–H532PubMedPubMedCentralCrossRef

82.

Jacquier A, Higgins CB, Martin AJ, Do L, Saloner D, Saeed M (2007) Injection of adeno-associated viral vector encoding vascular endothelial growth factor gene in infarcted swine myocardium: Mr measurements of left ventricular function and strain. Radiology 245:196–205PubMedCrossRef

83.

Saeed M, Martin A, Jacquier A, Bucknor M, Saloner D, Do L, Ursell P, Su H, Kan YW, Higgins CB (2008) Permanent coronary artery occlusion: cardiovascular mr imaging is platform for percutaneous transendocardial delivery and assessment of gene therapy in canine model. Radiology 249:560–571PubMedPubMedCentralCrossRef

84.

Sommer P, Grothoff M, Eitel C, Gaspar T, Piorkowski C, Gutberlet M, Hindricks G (2013) Feasibility of real-time magnetic resonance imaging-guided electrophysiology studies in humans. Europace 15:101–108PubMedCrossRef

85.

Bhagirath P, van der Graaf M, Karim R, Rhode K, Piorkowski C, Razavi R, Schwitter J, Gotte M (2015) Interventional cardiac magnetic resonance imaging in electrophysiology: advances toward clinical translation. Circ Arrhythm Electrophysiol 8:203–211PubMedCrossRef

86.

Dick AJ, Guttman MA, Raman VK, Peters DC, Pessanha BS, Hill JM, Smith S, Scott G, McVeigh ER, Lederman RJ (2003) Magnetic resonance fluoroscopy allows targeted delivery of mesenchymal stem cells to infarct borders in swine. Circulation 108:2899–2904PubMedPubMedCentralCrossRef

87.

Ebert SN, Taylor DG, Nguyen HL, Kodack DP, Beyers RJ, Xu Y, Yang Z, French BA (2007) Noninvasive tracking of cardiac embryonic stem cells in vivo using magnetic resonance imaging techniques. Stem Cells 25:2936–2944PubMedCrossRef

88.

Hill JM, Dick AJ, Raman VK, Thompson RB, Yu ZX, Hinds KA, Pessanha BS, Guttman MA, Varney TR, Martin BJ, Dunbar CE, McVeigh ER, Lederman RJ (2003) Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation 108:1009–1014PubMedPubMedCentralCrossRef

89.

Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE, Berman D, Czer LS, Marban L, Mendizabal A, Johnston PV, Russell SD, Schuleri KH, Lardo AC, Gerstenblith G, Marban E (2012) Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (caduceus): a prospective, randomised phase 1 trial. Lancet 379:895–904PubMedPubMedCentralCrossRef

90.

Qian L, Huang Y, Spencer CI, Foley A, Vedantham V, Liu L, Conway SJ, Fu JD, Srivastava D (2012) In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 485:593–598PubMedPubMedCentralCrossRef

91.

Anderson KR, Sutton MG, Lie JT (1979) Histopathological types of cardiac fibrosis in myocardial disease. J Pathol 128:79–85PubMedCrossRef

92.

Schelbert EB, Testa SM, Meier CG, Ceyrolles WJ, Levenson JE, Blair AJ, Kellman P, Jones BL, Ludwig DR, Schwartzman D, Shroff SG, Wong TC (2011) Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus. J Cardiovasc Magn Reson 13:16PubMedPubMedCentralCrossRef

93.

Jerosch-Herold M, Sheridan DC, Kushner JD, Nauman D, Burgess D, Dutton D, Alharethi R, Li D, Hershberger RE (2008) Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 295:H1234–H1242PubMedPubMedCentralCrossRef

94.

Klein C, Nekolla SG, Balbach T, Schnackenburg B, Nagel E, Fleck E, Schwaiger M (2004) The influence of myocardial blood flow and volume of distribution on late gd-dtpa kinetics in ischemic heart failure. J Magn Reson Imaging 20:588–593PubMedCrossRef

95.

Ugander M, Oki AJ, Hsu LY, Kellman P, Greiser A, Aletras AH, Sibley CT, Chen MY, Bandettini WP, Arai AE (2012) Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Eur Heart J 33:1268–1278PubMedPubMedCentralCrossRef

96.

Hamdani N, Paulus WJ, van Heerebeek L, Borbely A, Boontje NM, Zuidwijk MJ, Bronzwaer JG, Simonides WS, Niessen HW, Stienen GJ, van der Velden J (2009) Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction. Eur Heart J 30:1863–1872PubMedCrossRef

97.

Brilla CG (2000) Renin-angiotensin system mediated mechanisms: cardioreparation and cardioprotection. Heart 84(Suppl 1):i18–i19PubMedPubMedCentralCrossRef

98.

Assomull RG, Lyne JC, Keenan N, Gulati A, Bunce NH, Davies SW (2007) The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. Eur Heart J 28:1242–1249

99.

Baughman KL (2006) Diagnosis of myocarditis: death of dallas criteria. Circulation 113:593–595PubMedCrossRef

100.

Zagrosek A, Abdel-Aty H, Boye P, Wassmuth R, Messroghli D, Utz W, Rudolph A, Bohl S, Dietz R, Schulz-Menger J (2009) Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis. JACC Cardiovasc Imaging 2:131–138PubMedCrossRef

101.

Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, Vogelsberg H, Fritz P, Dippon J, Bock CT, Klingel K, Kandolf R, Sechtem U (2006) Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114:1581–1590PubMedCrossRef

102.

Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ (2005) Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26:1461–1474PubMedCrossRef

103.

Lurz P, Luecke C, Eitel I, Fohrenbach F, Frank C, Grothoff M, de Waha S, Rommel KP, Lurz JA, Klingel K, Kandolf R, Schuler G, Thiele H, Gutberlet M (2016) Comprehensive cardiac magnetic resonance imaging in patients with suspected myocarditis: the myoracer-trial. J Am Coll Cardiol 67:1800–1811PubMedCrossRef

104.

von Knobelsdorff-Brenkenhoff F, Mueller AK, Prothmann M, Hennig P, Dieringer MA, Schmacht L, Greiser A, Schulz-Menger J (2016) Cardiac fibrosis in aortic stenosis and hypertensive heart disease assessed by magnetic resonance t1 mapping. J Heart Valve Dis 25:527–533

105.

Bengtsson C, Ohman ML, Nived O, Rantapaa Dahlqvist S (2012) Cardiovascular event in systemic lupus erythematosus in northern sweden: incidence and predictors in a 7-year follow-up study. Lupus 21:452–459PubMedCrossRef

106.

Mavrogeni S, Karabela G, Stavropoulos E, Plastiras S, Spiliotis G, Gialafos E, Kolovou G, Sfikakis PP, Kitas GD (2014) Heart failure imaging patterns in systemic lupus erythematosus. Evaluation using cardiovascular magnetic resonance. Int J Cardiol 176:559–561PubMedCrossRef

107.

Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, Urowitz M, Fortin PR, Petri M, Barr S, Gordon C, Bae SC, Isenberg D, Zoma A, Aranow C, Dooley MA, Nived O, Sturfelt G, Steinsson K, Alarcon G, Senecal JL, Zummer M, Hanly J, Ensworth S, Pope J, Edworthy S, Rahman A, Sibley J, El-Gabalawy H, McCarthy T, St Pierre Y, Clarke A, Ramsey-Goldman R (2006) Mortality in systemic lupus erythematosus. Arthritis Rheum 54:2550–2557PubMedCrossRef

108.

Ballocca F, D’Ascenzo F, Moretti C, Omede P, Cerrato E, Barbero U, Abbate A, Bertero MT, Zoccai GB, Gaita F (2015) Predictors of cardiovascular events in patients with systemic lupus erythematosus (sle): a systematic review and meta-analysis. Eur J Prev Cardiol 22:1435–1441PubMedCrossRef

109.

Knockaert DC (2007) Cardiac involvement in systemic inflammatory diseases. Eur Heart J 28:1797–1804PubMedCrossRef

110.

Hinojar R, Foote L, Sangle S, Marber M, Mayr M, Carr-White G, D’Cruz D, Nagel E, Puntmann VO (2016) Native t1 and t2 mapping by cmr in lupus myocarditis: disease recognition and response to treatment. Int J Cardiol 222:717–726PubMedCrossRef

111.

Ishimori ML, Martin R, Berman DS, Goykhman P, Shaw LJ, Shufelt C, Slomka PJ, Thomson LE, Schapira J, Yang Y, Wallace DJ, Weisman MH, Bairey Merz CN (2011) Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus. JACC Cardiovasc Imaging 4:27–33PubMedCrossRef

112.

Varma N, Hinojar R, D’Cruz D, Arroyo Ucar E, Indermuehle A, Peel S, Greil G, Gaddum N, Chowienczyk P, Nagel E, Botnar RM, Puntmann VO (2014) Coronary vessel wall contrast enhancement imaging as a potential direct marker of coronary involvement: Integration of findings from cad and sle patients. JACC Cardiovasc Imaging 7:762–770PubMedPubMedCentralCrossRef

113.

Weber KT, Sun Y, Katwa LC (1996) Wound healing following myocardial infarction. Clin Cardiol 19:447–455PubMedCrossRef

114.

Rudolph A, Abdel-Aty H, Bohl S, Boye P, Zagrosek A, Dietz R, Schulz-Menger J (2009) Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol 53:284–291PubMedCrossRef

115.

Gonzalez A, Lopez B, Diez J (2005) New directions in the assessment and treatment of hypertensive heart disease. Curr Opin Nephrol Hypertens 14:428–434PubMedCrossRef

116.

Assayag P, Carre F, Chevalier B, Delcayre C, Mansier P, Swynghedauw B (1997) Compensated cardiac hypertrophy: arrhythmogenicity and the new myocardial phenotype. I. Fibrosis. Cardiovasc Res 34:439–444PubMedCrossRef

117.

Choudhury L, Mahrholdt H, Wagner A, Choi KM, Elliott MD, Klocke FJ, Bonow RO, Judd RM, Kim RJ (2002) Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40:2156–2164PubMedCrossRef

118.

Kim RJ, Judd RM (2003) Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: in vivo imaging of the pathologic substrate for premature cardiac death? J Am Coll Cardiol 41:1568–1572PubMedCrossRef

119.

Chan RH, Maron BJ, Olivotto I, Pencina MJ, Assenza GE, Haas T, Lesser JR, Gruner C, Crean AM, Rakowski H, Udelson JE, Rowin E, Lombardi M, Cecchi F, Tomberli B, Spirito P, Formisano F, Biagini E, Rapezzi C, De Cecco CN, Autore C, Cook EF, Hong SN, Gibson CM, Manning WJ, Appelbaum E, Maron MS (2014) Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation 130:484–495PubMedCrossRef

120.

O’Hanlon R, Grasso A, Roughton M, Moon JC, Clark S, Wage R, Webb J, Kulkarni M, Dawson D, Sulaibeekh L, Chandrasekaran B, Bucciarelli-Ducci C, Pasquale F, Cowie MR, McKenna WJ, Sheppard MN, Elliott PM, Pennell DJ, Prasad SK (2010) Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 56:867–874PubMedCrossRef

121.

Prinz C, Schwarz M, Ilic I, Laser KT, Lehmann R, Prinz EM, Bitter T, Vogt J, van Buuren F, Bogunovic N, Horstkotte D, Faber L (2013) Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy. Can J Cardiol 29:358–363PubMedCrossRef

122.

Liu S, Han J, Nacif MS, Jones J, Kawel N, Kellman P, Sibley CT, Bluemke DA (2012) Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance t1 mapping: sample size considerations for clinical trials. J Cardiovasc Magn Reson 14:90PubMedPubMedCentralCrossRef

123.

Brilla CG, Funck RC, Rupp H (2000) Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation 102:1388–1393PubMedCrossRef

124.

Tigen K, Karaahmet T, Kirma C, Dundar C, Pala S, Isiklar I, Cevik C, Kilicgedik A, Basaran Y (2010) Diffuse late gadolinium enhancement by cardiovascular magnetic resonance predicts significant intraventricular systolic dyssynchrony in patients with non-ischemic dilated cardiomyopathy. J Am Soc Echocardiogr 23:416–422PubMedCrossRef

125.

Ho CY, Lopez B, Coelho-Filho OR, Lakdawala NK, Cirino AL, Jarolim P, Kwong R, Gonzalez A, Colan SD, Seidman JG, Diez J, Seidman CE (2010) Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N Engl J Med 363:552–563PubMedPubMedCentralCrossRef

126.

Arenja N, Riffel JH, Fritz T, Andre F, Aus dem Siepen F, Mueller-Hennessen M, Giannitsis E, Katus HA, Friedrich MG, Buss SJ (2017) Diagnostic and prognostic value of long-axis strain and myocardial contraction fraction using standard cardiovascular mr imaging in patients with nonischemic dilated cardiomyopathies. Radiology 161184. doi:10.1148/radiol.2016161184

127.

Babar JL, Jones RG, Hudsmith L, Steeds R, Guest P (2010) Application of mr imaging in assessment and follow-up of congenital heart disease in adults. Radiographics 30:1145PubMedCrossRef

128.

Maceira AM, Joshi J, Prasad SK, Moon JC, Perugini E, Harding I, Sheppard MN, Poole-Wilson PA, Hawkins PN, Pennell DJ (2005) Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 111:186–193PubMedCrossRef

129.

Carlsson M, Saloner D, Martin AJ, Ursell PC, Saeed M (2010) Heterogeneous microinfarcts caused by coronary microemboli: evaluation with multidetector ct and mr imaging in a swine model. Radiology 254:718–728PubMedPubMedCentralCrossRef

130.

Debl K, Djavidani B, Buchner S, Heinicke N, Poschenrieder F, Feuerbach S, Riegger G, Luchner A (2009) Quantification of left-to-right shunting in adult congenital heart disease: phase-contrast cine mri compared with invasive oximetry. Br J Radiol 82:386–391PubMedCrossRef

131.

Markl M, Geiger J, Stiller B, Arnold R (2011) Impaired continuity of flow in congenital heart disease with single ventricle physiology. Interact Cardiovasc Thorac Surg 12:87–90PubMedCrossRef

132.

Broberg CS, Chugh SS, Conklin C, Sahn DJ, Jerosch-Herold M (2010) Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease. Circ Cardiovasc Imaging 3:727–734PubMedPubMedCentralCrossRef

133.

Neilan TG, Mongeon FP, Shah RV, Coelho-Filho O, Abbasi SA, Dodson JA, McMullan CJ, Heydari B, Michaud GF, John RM, Blankstein R, Jerosch-Herold M, Kwong RY (2014) Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation. JACC Cardiovasc Imaging 7:1–11PubMedCrossRef

134.

Murakami T, Ishiguro N, Higuchi K (2014) Transmission of systemic aa amyloidosis in animals. Vet Pathol 51:363–371PubMedCrossRef

135.

Sparrow PJ, Merchant N, Provost YL, Doyle DJ, Nguyen ET, Paul NS (2009) Ct and mr imaging findings in patients with acquired heart disease at risk for sudden cardiac death. Radiographics 29:805–823PubMedCrossRef

136.

Austin BA, Tang WH, Rodriguez ER, Tan C, Flamm SD, Taylor DO, Starling RC, Desai MY (2009) Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. JACC Cardiovasc Imaging 2:1369–1377PubMedCrossRef

137.

Hosch W, Bock M, Libicher M, Ley S, Hegenbart U, Dengler TJ, Katus HA, Kauczor HU, Kauffmann GW, Kristen AV (2007) Mr-relaxometry of myocardial tissue: significant elevation of t1 and t2 relaxation times in cardiac amyloidosis. Investig Radiol 42:636–642CrossRef

138.

Robbers LF, Baars EN, Brouwer WP, Beek AM, Hofman MB, Niessen HW, van Rossum AC, Marcu CB (2012) T1 mapping shows increased extracellular matrix size in the myocardium due to amyloid depositions. Circ Cardiovasc Imaging 5:423–426PubMedCrossRef

139.

Sado DM, Flett AS, Banypersad SM, White SK, Maestrini V, Quarta G, Lachmann RH, Murphy E, Mehta A, Hughes DA, McKenna WJ, Taylor AM, Hausenloy DJ, Hawkins PN, Elliott PM, Moon JC (2012) Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart 98:1436–1441PubMedCrossRef

140.

Paneni F, Beckman JA, Creager MA, Cosentino F (2013) Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part i. Eur Heart J 34:2436–2443PubMedPubMedCentralCrossRef

141.

From AM, Scott CG, Chen HH (2010) The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study. J Am Coll Cardiol 55:300–305PubMedCrossRef

142.

Schwartzkopff B, Brehm M, Mundhenke M, Strauer BE (2000) Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease. Hypertension 36:220–225PubMedCrossRef

143.

Tamarappoo BK, John BT, Reinier K, Teodorescu C, Uy-Evanado A, Gunson K, Jui J, Chugh SS (2012) Vulnerable myocardial interstitium in patients with isolated left ventricular hypertrophy and sudden cardiac death: a postmortem histological evaluation. J Am Heart Assoc 1:e001511PubMedPubMedCentralCrossRef

144.

Wong TC, Piehler K, Meier CG, Testa SM, Klock AM, Aneizi AA, Shakesprere J, Kellman P, Shroff SG, Schwartzman DS, Mulukutla SR, Simon MA, Schelbert EB (2012) Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation 126:1206–1216PubMedPubMedCentralCrossRef

145.

Ng AC, Auger D, Delgado V, van Elderen SG, Bertini M, Siebelink HM, van der Geest RJ, Bonetti C, van der Velde ET, de Roos A, Smit JW, Leung DY, Bax JJ, Lamb HJ (2012) Association between diffuse myocardial fibrosis by cardiac magnetic resonance contrast-enhanced t(1) mapping and subclinical myocardial dysfunction in diabetic patients: a pilot study. Circ Cardiovasc Imaging 5:51–59PubMedCrossRef

146.

Rijzewijk LJ, van der Meer RW, Lamb HJ, de Jong HW, Lubberink M, Romijn JA, Bax JJ, de Roos A, Twisk JW, Heine RJ, Lammertsma AA, Smit JW, Diamant M (2009) Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging. J Am Coll Cardiol 54:1524–1532PubMedCrossRef

Titel: Magnetic resonance imaging for characterizing myocardial diseases
verfasst von: Maythem Saeed
Hui Liu
Chang-Hong Liang
Mark W. Wilson
Publikationsdatum: 31.03.2017
Verlag: Springer Netherlands
Erschienen in: The International Journal of Cardiovascular Imaging / Ausgabe 9/2017
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI: https://doi.org/10.1007/s10554-017-1127-x

Neu im Fachgebiet Kardiologie

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Magnetic resonance imaging for characterizing myocardial diseases

Abstract

Neu im Fachgebiet Kardiologie

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Parodontalbehandlung verbessert Prognose bei Katheterablation

Update Kardiologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2017

Reproducibility of echocardiographic assessment of 2D-derived longitudinal strain parameters in a population-based study (the STANISLAS Cohort study)

Strut protrusion and shape impact on endothelial shear stress: insights from pre-clinical study comparing Mirage and Absorb bioresorbable scaffolds

Three-dimensional speckle tracking longitudinal strain is related to myocardial fibrosis determined by late-gadolinium enhancement

Accuracy and reproducibility of fast fractional flow reserve computation from invasive coronary angiography

Long-term outcome of patients with triphasic mitral flow with a mid-diastolic L wave: prognostic role of left atrial volume and N-terminal pro-brain natriuretic peptide

Ventricular pacing site separation by cardiac computed tomography: validation for the prediction of clinical response to cardiac resynchronization therapy

Neu im Fachgebiet Kardiologie

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Parodontalbehandlung verbessert Prognose bei Katheterablation

Update Kardiologie